Jamjoom Pharma board recommends transferring SAR 67.1M to retained earnings

08:43 AM (Mecca time) Argaam
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Jamjoom Pharmaceuticals Factory Co.’s (Jamjoom Pharma) board of directors recommended, on Dec. 31, 2025, to transfer the statutory reserve balance of SAR 67.13 million, as per the financial report of Sept. 30, 2025, to the retained earnings, according to a statement to Tadawul.

 

The proposal will be submitted for voting at the upcoming general assembly meeting and is subject to shareholders’ approval.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.